Benutzerspezifische Werkzeuge

2013

2013

Publikationen der Klinik für Kinder- und Jugendpsychiatrie und -psychotherapie des Jahres 2013.

Bock N, Koc E, Alter H, Roessner V, Becker A, Rothenberger A: Chronic Fluoxetine treatment changes S100B expression during postnatal rat brain development. J Child Adolesc Psychopharmacol, 23(7):481-9, 2013.

Brauns S, Gollub RL, Walton E, Hass J, Smolka MN, White T, Wassink TH, Calhoun VD, Ehrlich S: Genetic variation in GAD1 is associated with cortical thickness in the parahippocampal gyrus. J Psychiatr Res, 47: 872-9, 2013.

Buse J, Schoenefeld K, Münchau A, Roessner V : Neuromodulation in Tourette Syndrome: Dopamine and beyond. Neurosci Biobehav Rev , 37(6):1069-84, 2013.

Chen J, Calhoun VD, Pearlson GD, Perrone-Bizzozero N, Sui J, Turner JA, Bustillo JR, Ehrlich S, Sponheim S, Cañive J, Ho B, Liu J: Guided Exploration of Genomic Risk for Gray Matter Abnormalities in Schizophrenia Using Parallel Independent Component Analysis with Reference. Neuroimage , 83:384-96, 2013.

Ganos C, Roessner V , Münchau A: The functional anatomy of Gilles de la Tourette syndrome. Neurosci Biobehav Rev , 37(6):1050-62, 2013.

Gollub RL, Shoemaker JM, King MD, White T, Ehrlich S, Sponheim SR, Clark VP, Turner JA, Mueller BA, Magnotta V, O'Leary D, Ho BC, Brauns S, Manoach DS, Seidman L, Bustillo JR, Lauriello J, Bockholt J, Lim KO, Rosen BR, Schulz SC, Calhoun VD, Andreasen NC: The MCIC Collection: A Shared Repository of Multi-Modal, Multi-Site Brain Image Data from a Clinical Investigation of Schizophrenia. Neuroinformatics, 11(3):367-88, 2013.

Hass J, Walton E, Kirsten H, Liu J, Priebe L, Wolf C, Karbalai N, Gollub R, White T, Roessner V, Müller KU, Paus T, Smolka MN, Schumann G, IMAGEN Consortium, Scholz M, Cichon S, Calhoun V, Ehrlich S : A Genome-Wide Association Study Suggests Novel Loci Associated with a Schizophrenia-Related Brain-Based Phenotype. PLoS One, 8(6):e64872, 2013.

Kappel V, Ehrlich S, van Noort B: Anorexia nervosa aus neurowissenschaftlicher Sicht. PiD, 14(04):90-3, 2013.

Liu J, Chen J, Ehrlich S , Walton E, White T, Perrone-Bizzozero N, Bustillo JR, Turner JA, Calhoun VD: Methylation Patterns in Whole Blood Correlate With Symptoms in Schizophrenia Patients. Schizophr Bull , 40(4):769-76, 2013.

Macrì S, Onori MP, Roessner V , Laviola G: Animal Models Recapitulating the Multifactorial Origin of Tourette Syndrome. Int Rev Neurobiol , 112:211-37, 2013.

Mogwitz S, Buse J, Ehrlich S, Roessner V : Clinical Pharmacology of Dopamine-Modulating Agents in Tourette's Syndrome. Int Rev Neurobiol , 112:281-349, 2013.

Ness V, Beste C : The role of the striatum in goal activation of cascaded actions. Neuropsychologia, 51(13):2562-71 , 2013.

Ocklenburg S, Beste C, Güntürkün O: Handedness: a neurogenetic shift in perspective. Neurosci Biobehav Rev, 126(3):279-84, 2013.

Roessner V, Buse J, Schultze F, Rothenberger A, Becker A: The role of obsessive-compulsive symptoms in the psychopathological profile of children with chronic tic disorder and attention-deficit hyperactivity disorder. Z Kinder Jugendpsychiatr Psychother, 41(3):163-71, 2013.

Roessner V, Hoekstra PJ: European Multicenter Tics in Children Studies (EMTICS): exploring the onset and course of tic disorders. Eur Child Adolesc Psychiatry , 22(7):451-2, 2013.

Roessner V, Rothenberger A: Pharmacological treatment of tics. In: Martino D, Leckman J (Hrsg.): Tourette Syndrome . New York: Oxford University Press; S. 524-52, 2013.

Roessner V: ADHS, ADS oder HKS? Die kinder- und jugendpsychiatrische Diagnose ADHS. Neuro aktuell, 8(27:221):22-6, 2013.

Rothenberger A, Roessner V: Functional neuroimaging investigations of motor networks in Tourette syndrome. Behav Neurology, 27(1):47-55, 2013.

Rothenberger A, Roessner V: The phenomenology of attention-deficit/hyperactivity disorder (ADHD) in Tourette Syndrome (TS) – modification while co-existing? In: Martino D, Leckman J (Hrsg.) Tourette Syndrome . New York: Oxford University Press; S. 26-49, 2013.

Schmitt J, Buske-Kirschbaum A, Trikojat K, Roessner V , Romanos M: Neurodermitis als Risikofaktor für die Entstehung einer Aufmerksamkeits-Defizit/Hyperaktivitäts-Störung – Epidemiologische Evidenz und mögliche Mechanismen. Pädiatrische Allergologie in Klinik und Praxis, 2:17-21, 2013.

Scholz K, Weiß J: Multifamilientherapie bei Patienten mit Essstörungen - Die Ressourcen der Familien nutzen. PiD , 14(04):28-31, 2013.

Walton E, Geisler D, Hass J , Liu J, Turner J, Yendiki A, Smolka MN, Ho BC, Manoach DS, Gollub RL, Roessner V , Calhoun VD, Ehrlich S : The Impact of Genome-Wide Supported Schizophrenia Risk Variants in the Neurogranin Gene on Brain Structure and Function. PLoS One, 8(10):e76815, 2013.

Walton E, Turner JA, Ehrlich S: Neuroimaging as a potential biomarker to optimize psychiatric research and treatment. Int Rev Psychiatry, 25(5):619-31, 2013.

Yeo RA, Martinez D, Pommy J, Ehrlich S , Schulz SC, Ho B-C, Bustillo JR, Calhoun VD: The impact of parent socio-economic status on executive functioning and cortical morphology in individuals with schizophrenia and healthy controls. Psycholog Med , 44(6):1257-65, 2013.